For its 2nd anniversary, Callisto DataHub offers free annotated datasets of 50 suspected lung cancer X-rays and 50 prostate cancer MRI cases for commercial use ...
Stocktwits on MSN
CADL stock gets a bullish call just weeks before crucial prostate cancer data reveal
The firm stated that the stock is deeply undervalued, with a discounted cash flow estimate of around $30 per share. ・Investors are awaiting extended phase 3 data for CAN-2409 in prostate cancer, as ...
The free datasets include 50 cases of lung cancer-suspected chest X-rays with lesion bounding boxes and 50 cases of prostate cancer MRI with lesion segmentations (PI-RADS 4 and 5). Both datasets are ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results